Release Date: February 18, 2025
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
Q: Why did Semler Scientific decide to do the convertible note offering? A: Eric Semler, Independent Chairman of the Board, explained that the company chose the convertible note offering as it is a cheaper source of funding and less dilutive to stockholders. The offering allowed them to raise a large amount of capital quickly, initially targeting $75 million but increasing to $100 million due to high demand. The cap call created a conversion premium 75% higher than the stock's trading price at the time of the announcement.
Q: What's driving the underlying trends in the business, and what are the expectations for 2025? A: Jennifer Oliva Herrington, Chief Operating Officer, stated that despite government decisions affecting payment for risk adjustment for PAD, the company continues to add new clients for QuantaFlo software licenses. They are expanding their customer base beyond managed care to clinics and value-based care providers. The priority for 2025 is to minimize declines in QuantaFlo revenue while supporting and growing operations related to other cardiovascular diseases.
Q: What are Semler Scientific's expectations from the new government in Washington, D.C. regarding crypto? A: Eric Semler expressed excitement about the strong government support for Bitcoin, particularly the repeal of SB 21, which allows major banks to custody Bitcoin. This expansion may increase the likelihood of large public companies adding Bitcoin to their balance sheets. Semler believes the benefits of the repeal are not yet fully reflected in Bitcoin's current price.
Q: How did Semler Scientific perform financially in Q4 2024? A: Renae Cormier, Chief Financial Officer, reported that total revenues for Q4 2024 were $12.4 million, down 18% from Q4 2023. Operating expenses decreased by 29% year-over-year, and income from operations increased by 40% to $3.5 million. The company also recorded a $28.8 million gain from the change in fair value of Bitcoin holdings, contributing to a net income of $29.2 million for the quarter.
Q: What is the status of Semler Scientific's Bitcoin holdings and strategy? A: Eric Semler highlighted that the company owns 3,192 bitcoins valued at over $300 million, making it the tenth largest corporate holder of Bitcoin. They have invested $280 million in Bitcoin, viewing it as digital gold with long-term investment potential. The company remains committed to growing its Bitcoin holdings and will evaluate financing options to maximize stakeholder value.
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
This article first appeared on GuruFocus.Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.